Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 115, Issue 19
May 13 2010
Issue Cover

Table of Contents

INSIDE BLOOD

INSIDE BLOOD
Antigens in CLL: themes and variations
Kostas Stamatopoulos
View Articletitled, Antigens in CLL: themes and variations
CLINICAL TRIALS
Combating cancer with allogeneic T cells
J. H. Frederik Falkenburg
View Articletitled, Combating cancer with allogeneic T cells
HEMATOPOIESIS & STEM CELLS
Cholesterol activates vascular niche and hematopoiesis
Shahin Rafii,Daniel Nolan
View Articletitled, Cholesterol activates vascular niche and hematopoiesis
INSIDE BLOOD
Coding and noncoding: the CLL mix
Deepa Sampath,George A. Calin
View Articletitled, Coding and noncoding: the CLL mix
MYELOID NEOPLASIA
The Erg-onomics of myeloproliferation in Down syndrome
Michael A. McDevitt
View Articletitled, The Erg-onomics of myeloproliferation in Down syndrome

REVIEW ARTICLES

Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update
Ruth Seggewiss,Hermann Einsele
View Articletitled, Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

CLINICAL TRIALS AND OBSERVATIONS

Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Clinical Trials & Observations
Edus H. Warren,Nobuharu Fujii,Yoshiki Akatsuka,Colette N. Chaney,Jeffrey K. Mito,Keith R. Loeb,Ted A. Gooley,Michele L. Brown,Kevin K. W. Koo,Kellie V. Rosinski,Seishi Ogawa,Aiko Matsubara,Frederick R. Appelbaum,Stanley R. Riddell
View Articletitled, Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
Supplemental data
End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care
Clinical Trials & Observations
Christina K. Ullrich,Veronica Dussel,Joanne M. Hilden,Jan W. Sheaffer,Leslie Lehmann,Joanne Wolfe
View Articletitled, End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care

HEMATOPOIESIS AND STEM CELLS

Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis
Ana L. Gomes,Tânia Carvalho,Jacinta Serpa,Cheila Torre,Sérgio Dias
View Articletitled, Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis
Contrasting effects of Sox17- and Sox18-sustained expression at the onset of blood specification
Brief Report
Alicia G. Serrano,Arnaud Gandillet,Stella Pearson,Georges Lacaud,Valerie Kouskoff
View Articletitled, Contrasting effects of Sox17- and Sox18-sustained expression at the onset of blood specification
Supplemental data

IMMUNOBIOLOGY

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Sebastian Drube,Sylvia Heink,Sabine Walter,Tobias Löhn,Mandy Grusser,Alexander Gerbaulet,Luciana Berod,Julia Schons,Anne Dudeck,Jenny Freitag,Stefan Grotha,Daniela Reich,Olga Rudeschko,Johannes Norgauer,Karin Hartmann,Axel Roers,Thomas Kamradt
View Articletitled, The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells
Supplemental data

LYMPHOID NEOPLASIA

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin
Charles C. Chu,Rosa Catera,Lu Zhang,Sebastien Didier,Briana M. Agagnina,Rajendra N. Damle,Matthew S. Kaufman,Jonathan E. Kolitz,Steven L. Allen,Kanti R. Rai,Nicholas Chiorazzi
View Articletitled, Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin
Supplemental data
13q14 deletions in CLL involve cooperating tumor suppressors
Alexey Palamarchuk,Alexey Efanov,Natalya Nazaryan,Urmila Santanam,Hansjuerg Alder,Laura Rassenti,Thomas Kipps,Carlo M. Croce,Yuri Pekarsky
View Articletitled, 13q14 deletions in CLL involve cooperating tumor suppressors
Genetic variation in the folate metabolic pathway and risk of childhood leukemia
Tracy J. Lightfoot,W. Thomas Johnston,Dan Painter,Jill Simpson,Eve Roman,Chris F. Skibola,Martyn T. Smith,James M. Allan,G. Malcolm Taylor,on behalf of the United Kingdom Childhood Cancer Study
View Articletitled, Genetic variation in the folate metabolic pathway and risk of childhood leukemia
Transactivation of the dopamine receptor 3 gene by a single provirus integration results in development of B-cell lymphoma in transgenic mice generated from retrovirally transduced embryonic stem cells
Yumi Hirata,Sanae Hamanaka,Masafumi Onodera
View Articletitled, Transactivation of the dopamine receptor 3 gene by a single provirus integration results in development of B-cell lymphoma in transgenic mice generated from retrovirally transduced embryonic stem cells
Supplemental data
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
Matthew J. Streetly,Lenushka Maharaj,Simon Joel,Steve A. Schey,John G. Gribben,Finbarr E. Cotter
View Articletitled, GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27
Michela Frenquelli,Marta Muzio,Cristina Scielzo,Claudia Fazi,Lydia Scarfò,Claudia Rossi,Giuliana Ferrari,Paolo Ghia,Federico Caligaris-Cappio
View Articletitled, MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27
Supplemental data
Natural killer–cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma
Martin Stern,Gerhard Opelz,Bernd Döhler,Christoph Hess
View Articletitled, Natural killer–cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma

MYELOID NEOPLASIA

Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome
Brief Report
Ashley P. Ng,Craig D. Hyland,Donald Metcalf,Catherine L. Carmichael,Stephen J. Loughran,Ladina Di Rago,Benjamin T. Kile,Warren S. Alexander
View Articletitled, Trisomy of <em>Erg</em> is required for myeloproliferation in a mouse model of Down syndrome
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1
Maria de la Luz Sierra,Shuhei Sakakibara,Paola Gasperini,Ombretta Salvucci,Kan Jiang,Peter J. McCormick,Marta Segarra,Jim Stone,Dragan Maric,Jinfang Zhu,Xiaolan Qian,Douglas R. Lowy,Giovanna Tosato
View Articletitled, The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1
Supplemental data

THROMBOSIS AND HEMOSTASIS

Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin
Nicola J. Mutch,Ruchira Engel,Shirley Uitte de Willige,Helen Philippou,Robert A. S. Ariëns
View Articletitled, Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin

TRANSFUSION MEDICINE

Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope
Krystalyn E. Hudson,Eugene Lin,Jeanne E. Hendrickson,Aron E. Lukacher,James C. Zimring
View Articletitled, Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope
Supplemental data

VASCULAR BIOLOGY

Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation
Pavel Uhrin,Jan Zaujec,Johannes M. Breuss,Damla Olcaydu,Peter Chrenek,Hannes Stockinger,Elke Fuertbauer,Markus Moser,Paula Haiko,Reinhard Fässler,Kari Alitalo,Bernd R. Binder,Dontscho Kerjaschki
View Articletitled, Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation
Supplemental data

ERRATA

Subramanian KK, Jia Y, Zhu D, et al. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood. 2007;109(9):4028–4037.
View Articletitled, Subramanian KK, Jia Y, Zhu D, et al. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. <em>Blood</em>. 2007;109(9):<span class="related-article">4028–4037</span>.
Eberhard Y, McDermott SP, Wang X, et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood. 2009;114(14):3064–3073.
View Articletitled, Eberhard Y, McDermott SP, Wang X, et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. <em>Blood</em>. 2009;114(14):<span class="related-article">3064–3073</span>.
Salles II, Thijs T, Brunaud C, et al. Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34+ cells are functionally active in an ex vivo flow model of thrombosis. Blood. 2009;114(24):5044–5051.
View Articletitled, Salles II, Thijs T, Brunaud C, et al. Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34<sup>+</sup> cells are functionally active in an ex vivo flow model of thrombosis. <em>Blood</em>. 2009;114(24):<span class="related-article">5044–5051</span>.
Stewart KA, Richardson PG, San-Miguel JF. How I treat multiple myeloma in younger patients. Blood. 2009;114(27):5436–5443.
View Articletitled, Stewart KA, Richardson PG, San-Miguel JF. How I treat multiple myeloma in younger patients. <em>Blood</em>. 2009;114(27):<span class="related-article">5436–5443</span>.
Nowak D, Ogawa S, Müschen M, et al. SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Blood. 2010;115(5):1049–1053.
View Articletitled, Nowak D, Ogawa S, Müschen M, et al. SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. <em>Blood</em>. 2010;115(5):<span class="related-article">1049–1053</span>.
All Issues

Advertisement intended for health care professionals

Mosunetuzumab next up to bat … is it a home run?
Novel CAR T cells to combat antigen escape in AML
Heme fuels venetoclax resistance in multiple myeloma
Introduction to a review series on mantle cell lymphoma: sands shifting in the darkness
Sequential epigenetic therapy in AML

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals